SUMMARY
Yuting Huang, M.B.B.S., Ph.D., has a translational scientific background in cancer immunology, stem cell research and gene therapy.
Dr. Huang's scientific endeavors are concentrated on nonviral gene therapy for treating rare diseases associated with the liver and pancreas. She is dedicated to advancing gene therapy techniques for immunotherapy applications in gastrointestinal cancers, including colorectal cancer, liver cancer, pancreatic cancer and bile duct cancer. In the realm of clinical research, Dr. Huang is committed to leveraging cutting-edge artificial intelligence and machine learning technologies to enhance people's outcomes and reduce healthcare disparities.
Focus areas
- Nonviral gene therapy targeting the liver and pancreas for the treatment of rare diseases.
- New treatments, especially immunotherapy, for gastrointestinal cancers, including colorectal cancer, liver cancer, pancreatic cancer and bile duct cancer.
- The application of artificial intelligence and machine learning to improve individual's outcomes and decrease healthcare disparities.
Significance to patient care
Gene therapy is increasingly at the forefront of medical advancement. It holds promise for treating multiple rare diseases and now shows rapid advancement in cancer treatment. Dr. Huang's dedication to developing gene-based immunotherapy for gastrointestinal cancer is particularly noteworthy. Her approach seeks to create new, effective and universally available treatment strategies.
Artificial intelligence is becoming an integral part of people's lives, with significant bearing for the future of healthcare. Dr. Huang also concentrates on harnessing artificial intelligence within clinical settings, aiming to reduce disparities and improve people's care across the board.
Professional highlights
- Patent co-inventor, Compositions and Methods for Coronavirus Detection, US20230184766A1, WO2021222772A2, patents pending.
- Patent co-inventor, Compositions and Methods for Treating Wilson's Disease, WO2023230466A1, patent pending.
- Patent co-inventor, Hydrodynamic Gene Delivery, WO2022204535A1, patent pending.
- Artificial Intelligence-Machine Learning Enablement Award, Mayo Clinic Center for Digital Health in partnership with Mayo Clinic Office of Equity, Inclusion and Diversity and supported with a grant from Dalio Philanthropies, 2023.
- Basic Science Travel Award, Digestive Disease Week, 2022 and 2023.
- Outstanding Manuscript Award, American Society for Gastrointestinal Endoscopy, 2022.
- Patent co-inventor, Gene Probe Composition and Kit for Detecting Epithelial Ovarian Cancer, CN103276060B, 2014.
- Patent co-inventor, Spontaneous Lymphocyte Highly Metastatic Human Ovarian Sarcomatoid Carcinoma Cell Line, CN101845418B, 2012.